SMD 5047Alternative Names: SMD-5047
Latest Information Update: 01 Jul 2016
At a glance
- Originator Sirenas Marine Discovery
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 01 Jul 2016 Early research in Cancer in USA (unspecified route)
- 01 Jul 2016 SMD 5047 is available for licensing as of 01 Jul 2016. http://sirenasmd.com/